Occudo Quantitative Strategies’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,324
Closed -$3.45M 954
2025
Q4
$3.45M Buy
25,324
+18,969
+298% +$2.73M 0.23% 134
2025
Q3
$937K Buy
6,355
+4,634
+269% +$643K 0.11% 256
2025
Q2
$223K Buy
+1,721
New +$208K 0.03% 525
2025
Q1
Sell
-20,020
Closed -$2.32M 951
2024
Q4
$2.32M Buy
+20,020
New +$2.53M 0.42% 54
2024
Q3
Sell
-2,193
Closed -$297K 1050
2024
Q2
$297K Buy
+2,193
New +$298K 0.05% 460
2023
Q4
Sell
-8,419
Closed -$766K 1251
2023
Q3
$766K Buy
8,419
+6,337
+304% +$654K 0.1% 355
2023
Q2
$234K Sell
2,082
-35,686
-94% -$3.77M 0.02% 809
2023
Q1
$3.95M Buy
+37,768
New +$3.94M 0.36% 61
2022
Q2
Sell
-72,940
Closed -$6.22M 1419
2022
Q1
$6.22M Buy
72,940
+30,874
+73% +$2.96M 0.52% 10
2021
Q4
$5.04M Buy
+42,066
New +$5.22M 0.45% 28
2021
Q3
Sell
-10,602
Closed -$1.27M 1169
2021
Q2
$1.27M Buy
10,602
+2,839
+37% +$324K 0.19% 148
2021
Q1
$817K Buy
+7,763
New +$787K 0.18% 182

Other funds holding XYL

Occudo Quantitative Strategies's XYL Position: Q1 2026 in Review

Occudo Quantitative Strategies sold out of Xylem (XYL) in Q1 2026, closing a stake of 25,324 shares — an estimated $3.45M sold.

Occudo Quantitative Strategies first reported a position in XYL in Q1 2021 and held it in 12 quarters. The position peaked at $6.22M in Q1 2022. 1,111 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Occudo Quantitative Strategies reported no remaining Xylem position as of Q1 2026 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 25,324 Xylem shares in Q1 2026, an estimated $3.45M.
  • Occudo Quantitative Strategies first reported a position in Xylem in Q1 2021 and held it in 12 quarters.
  • Occudo Quantitative Strategies's Xylem position peaked at $6.22M in Q1 2022.
  • 1,111 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.